Literature DB >> 26562495

Identification of a CYP19 Gene Single-Nucleotide Polymorphism Associated with a Reduced Risk of Coronary Heart Disease.

Bei Wang1, Zhen-Yan Fu1, Yi-Tong Ma1, Ding Huang1, Fen Liu1, Chun-Lan Dong1, Ting Wang1, Ya-Jie Meng1.   

Abstract

OBJECTIVE: An imbalance in sex hormone ratios has been identified in coronary heart disease (CHD), and as a key enzyme in the conversion of androgen to estrogen, aromatase plays an important role in the balance of sex hormone levels. However, there is a paucity of research into the potential roles of aromatase in CHD. In this study, we investigated associations between single-nucleotide polymorphisms (SNPs) in the CYP19 gene, which encodes aromatase, and CHD.
METHODS: We collected 1706 blood samples from CHD patients and control participants and used propensity score matching techniques to match case and control groups with respect to confounding factors. In a final study population, including 596 individuals, we conducted a case-control study to identify associations between three SNPs in CYP19 and CHD using χ(2) or Fisher exact tests, and binary logistic regression analysis. Differences in lipid levels and parameters of echocardiography among individuals with different genotypes were assessed by one-way analysis of variance.
RESULTS: The distributions of rs2289105 alleles in the CYP19 gene differed significantly between the CHD and control groups (p = 0.014), and the heterozygote CT genotype was associated with a significantly lower risk of CHD compared to the homozygous wild-type CC genotype (p = 0.0063 and odds ratio = 0.575). However, blood lipid levels and echocardiographic parameters among individuals with different genotypes did not differ between the CHD and control groups.
CONCLUSIONS: The CT genotype of the rs2289105 polymorphism in the CYP19 gene is associated with a decreased risk of CHD and may be a genetic marker of protection from CHD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26562495      PMCID: PMC4742981          DOI: 10.1089/gtmb.2015.0157

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  51 in total

1.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

Authors: 
Journal:  J Hypertens       Date:  1999-02       Impact factor: 4.844

2.  A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association.

Authors:  W G Austen; J E Edwards; R L Frye; G G Gensini; V L Gott; L S Griffith; D C McGoon; M L Murphy; B B Roe
Journal:  Circulation       Date:  1975-04       Impact factor: 29.690

3.  Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies.

Authors:  Sotirios Tsimikas; Jennifer L Hall
Journal:  J Am Coll Cardiol       Date:  2012-08-21       Impact factor: 24.094

4.  SNP rs2470152 in CYP19 is correlated to aromatase activity in Chinese polycystic ovary syndrome patients.

Authors:  Xin-Lin Zhang; Cheng-Wei Zhang; Pei Xu; Feng-Jing Liang; Ye-Na Che; Yan-Jie Xia; Yun-Xia Cao; Xiao-Ke Wu; Wen-Jun Wang; Long Yi; Qian Gao; Yong Wang
Journal:  Mol Med Rep       Date:  2011-10-03       Impact factor: 2.952

5.  Sex hormone ratio changes in men and postmenopausal women with coronary artery disease.

Authors:  Hong He; Falin Yang; Xianxi Liu; Xianwei Zeng; Qin Hu; Qing Zhu; Bing Tu
Journal:  Menopause       Date:  2007 May-Jun       Impact factor: 2.953

6.  Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women.

Authors:  Christopher A Haiman; Laure Dossus; V Wendy Setiawan; Daniel O Stram; Alison M Dunning; Gilles Thomas; Michael J Thun; Demetrius Albanes; David Altshuler; Eva Ardanaz; Heiner Boeing; Julie Buring; Noël Burtt; Eugenia E Calle; Stephen Chanock; Françoise Clavel-Chapelon; Graham A Colditz; David G Cox; Heather Spencer Feigelson; Susan E Hankinson; Richard B Hayes; Brian E Henderson; Joel N Hirschhorn; Robert Hoover; David J Hunter; Rudolf Kaaks; Laurence N Kolonel; Loïc Le Marchand; Per Lenner; Eiliv Lund; Salvatore Panico; Petra H Peeters; Malcolm C Pike; Elio Riboli; Anne Tjonneland; Ruth Travis; Dimitrios Trichopoulos; Sholom Wacholder; Regina G Ziegler
Journal:  Cancer Res       Date:  2007-02-26       Impact factor: 12.701

7.  Growth and hormonal profile from birth to adolescence of a girl with aromatase deficiency.

Authors:  Nishant Verma; Vandana Jain; Shweta Birla; Richa Jain; Arundhati Sharma
Journal:  J Pediatr Endocrinol Metab       Date:  2012       Impact factor: 1.634

Review 8.  History of aromatase: saga of an important biological mediator and therapeutic target.

Authors:  R J Santen; H Brodie; E R Simpson; P K Siiteri; A Brodie
Journal:  Endocr Rev       Date:  2009-04-23       Impact factor: 19.871

9.  A case of Aromatase deficiency due to a novel CYP19A1 mutation.

Authors:  Lucia Gagliardi; Hamish S Scott; Jinghua Feng; David J Torpy
Journal:  BMC Endocr Disord       Date:  2014-02-19       Impact factor: 2.763

10.  Common variants associated with plasma triglycerides and risk for coronary artery disease.

Authors:  Ron Do; Cristen J Willer; Ellen M Schmidt; Sebanti Sengupta; Chi Gao; Gina M Peloso; Stefan Gustafsson; Stavroula Kanoni; Andrea Ganna; Jin Chen; Martin L Buchkovich; Samia Mora; Jacques S Beckmann; Jennifer L Bragg-Gresham; Hsing-Yi Chang; Ayşe Demirkan; Heleen M Den Hertog; Louise A Donnelly; Georg B Ehret; Tõnu Esko; Mary F Feitosa; Teresa Ferreira; Krista Fischer; Pierre Fontanillas; Ross M Fraser; Daniel F Freitag; Deepti Gurdasani; Kauko Heikkilä; Elina Hyppönen; Aaron Isaacs; Anne U Jackson; Asa Johansson; Toby Johnson; Marika Kaakinen; Johannes Kettunen; Marcus E Kleber; Xiaohui Li; Jian'an Luan; Leo-Pekka Lyytikäinen; Patrik K E Magnusson; Massimo Mangino; Evelin Mihailov; May E Montasser; Martina Müller-Nurasyid; Ilja M Nolte; Jeffrey R O'Connell; Cameron D Palmer; Markus Perola; Ann-Kristin Petersen; Serena Sanna; Richa Saxena; Susan K Service; Sonia Shah; Dmitry Shungin; Carlo Sidore; Ci Song; Rona J Strawbridge; Ida Surakka; Toshiko Tanaka; Tanya M Teslovich; Gudmar Thorleifsson; Evita G Van den Herik; Benjamin F Voight; Kelly A Volcik; Lindsay L Waite; Andrew Wong; Ying Wu; Weihua Zhang; Devin Absher; Gershim Asiki; Inês Barroso; Latonya F Been; Jennifer L Bolton; Lori L Bonnycastle; Paolo Brambilla; Mary S Burnett; Giancarlo Cesana; Maria Dimitriou; Alex S F Doney; Angela Döring; Paul Elliott; Stephen E Epstein; Gudmundur Ingi Eyjolfsson; Bruna Gigante; Mark O Goodarzi; Harald Grallert; Martha L Gravito; Christopher J Groves; Göran Hallmans; Anna-Liisa Hartikainen; Caroline Hayward; Dena Hernandez; Andrew A Hicks; Hilma Holm; Yi-Jen Hung; Thomas Illig; Michelle R Jones; Pontiano Kaleebu; John J P Kastelein; Kay-Tee Khaw; Eric Kim; Norman Klopp; Pirjo Komulainen; Meena Kumari; Claudia Langenberg; Terho Lehtimäki; Shih-Yi Lin; Jaana Lindström; Ruth J F Loos; François Mach; Wendy L McArdle; Christa Meisinger; Braxton D Mitchell; Gabrielle Müller; Ramaiah Nagaraja; Narisu Narisu; Tuomo V M Nieminen; Rebecca N Nsubuga; Isleifur Olafsson; Ken K Ong; Aarno Palotie; Theodore Papamarkou; Cristina Pomilla; Anneli Pouta; Daniel J Rader; Muredach P Reilly; Paul M Ridker; Fernando Rivadeneira; Igor Rudan; Aimo Ruokonen; Nilesh Samani; Hubert Scharnagl; Janet Seeley; Kaisa Silander; Alena Stančáková; Kathleen Stirrups; Amy J Swift; Laurence Tiret; Andre G Uitterlinden; L Joost van Pelt; Sailaja Vedantam; Nicholas Wainwright; Cisca Wijmenga; Sarah H Wild; Gonneke Willemsen; Tom Wilsgaard; James F Wilson; Elizabeth H Young; Jing Hua Zhao; Linda S Adair; Dominique Arveiler; Themistocles L Assimes; Stefania Bandinelli; Franklyn Bennett; Murielle Bochud; Bernhard O Boehm; Dorret I Boomsma; Ingrid B Borecki; Stefan R Bornstein; Pascal Bovet; Michel Burnier; Harry Campbell; Aravinda Chakravarti; John C Chambers; Yii-Der Ida Chen; Francis S Collins; Richard S Cooper; John Danesh; George Dedoussis; Ulf de Faire; Alan B Feranil; Jean Ferrières; Luigi Ferrucci; Nelson B Freimer; Christian Gieger; Leif C Groop; Vilmundur Gudnason; Ulf Gyllensten; Anders Hamsten; Tamara B Harris; Aroon Hingorani; Joel N Hirschhorn; Albert Hofman; G Kees Hovingh; Chao Agnes Hsiung; Steve E Humphries; Steven C Hunt; Kristian Hveem; Carlos Iribarren; Marjo-Riitta Järvelin; Antti Jula; Mika Kähönen; Jaakko Kaprio; Antero Kesäniemi; Mika Kivimaki; Jaspal S Kooner; Peter J Koudstaal; Ronald M Krauss; Diana Kuh; Johanna Kuusisto; Kirsten O Kyvik; Markku Laakso; Timo A Lakka; Lars Lind; Cecilia M Lindgren; Nicholas G Martin; Winfried März; Mark I McCarthy; Colin A McKenzie; Pierre Meneton; Andres Metspalu; Leena Moilanen; Andrew D Morris; Patricia B Munroe; Inger Njølstad; Nancy L Pedersen; Chris Power; Peter P Pramstaller; Jackie F Price; Bruce M Psaty; Thomas Quertermous; Rainer Rauramaa; Danish Saleheen; Veikko Salomaa; Dharambir K Sanghera; Jouko Saramies; Peter E H Schwarz; Wayne H-H Sheu; Alan R Shuldiner; Agneta Siegbahn; Tim D Spector; Kari Stefansson; David P Strachan; Bamidele O Tayo; Elena Tremoli; Jaakko Tuomilehto; Matti Uusitupa; Cornelia M van Duijn; Peter Vollenweider; Lars Wallentin; Nicholas J Wareham; John B Whitfield; Bruce H R Wolffenbuttel; David Altshuler; Jose M Ordovas; Eric Boerwinkle; Colin N A Palmer; Unnur Thorsteinsdottir; Daniel I Chasman; Jerome I Rotter; Paul W Franks; Samuli Ripatti; L Adrienne Cupples; Manjinder S Sandhu; Stephen S Rich; Michael Boehnke; Panos Deloukas; Karen L Mohlke; Erik Ingelsson; Goncalo R Abecasis; Mark J Daly; Benjamin M Neale; Sekar Kathiresan
Journal:  Nat Genet       Date:  2013-10-06       Impact factor: 38.330

View more
  5 in total

1.  Association between rs10046, rs1143704, rs767199, rs727479, rs1065778, rs1062033, rs1008805, and rs700519 polymorphisms in aromatase (CYP19A1) gene and Alzheimer's disease risk: a systematic review and meta-analysis involving 11,051 subjects.

Authors:  Yuxuan Song; Yi Lu; Zhen Liang; Yongjiao Yang; Xiaoqiang Liu
Journal:  Neurol Sci       Date:  2019-07-05       Impact factor: 3.307

2.  Sex-specific association of SH2B3 and SMARCA4 polymorphisms with coronary artery disease susceptibility.

Authors:  Yuqiang Ji; Yanbin Song; Qingwen Wang; Pengcheng Xu; Zhao Zhao; Xia Li; Nan Wang; Tianbo Jin; Chao Chen
Journal:  Oncotarget       Date:  2017-07-31

Review 3.  The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy.

Authors:  Andrea Iorga; Christine M Cunningham; Shayan Moazeni; Gregoire Ruffenach; Soban Umar; Mansoureh Eghbali
Journal:  Biol Sex Differ       Date:  2017-10-24       Impact factor: 5.027

4.  A phenomics-based approach for the detection and interpretation of shared genetic influences on 29 biochemical indices in southern Chinese men.

Authors:  Yanling Hu; Aihua Tan; Lei Yu; Chenyang Hou; Haofa Kuang; Qunying Wu; Jinghan Su; Qingniao Zhou; Yuanyuan Zhu; Chenqi Zhang; Wei Wei; Lianfeng Li; Weidong Li; Yuanjie Huang; Hongli Huang; Xing Xie; Tingxi Lu; Haiying Zhang; Xiaobo Yang; Yong Gao; Tianyu Li; Yonghua Jiang; Zengnan Mo
Journal:  BMC Genomics       Date:  2019-12-16       Impact factor: 3.969

5.  The impact of CYP19A1 variants and haplotypes on breast cancer risk, clinicopathological features and prognosis.

Authors:  Ahmad Mohammed Alwan; Fahimeh Afzaljavan; Jalil Tavakol Afshari; Fatemeh Homaei Shandiz; Matineh Barati Bagherabad; Elham Vahednia; Nahid Kheradmand; Alireza Pasdar
Journal:  Mol Genet Genomic Med       Date:  2021-05-20       Impact factor: 2.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.